«The results of the ION studies demonstrated highly
satisfactory cure rates with a fixed dose combination of sofosbuvir / ledipasvir among patients with genotype 1 HCV infection without the use of either injectable interferon, which causes miserable flu - like symptoms, or ribavirin, an antiviral pill associated with a variety of troublesome side effects, including anemia and rash,» Professor Peck - Radosavljevic continued.